Company: ARTL
Filing Date: 2025-03-03
Form Type: 10-K
Source: 0001640334-25-000335
Chunk: 496

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-03-03
Form: 10-K
Item: Item 1C
Chunk 496
---
Subject to Options and Warrants Exercisable  Total Shares Beneficially Owned Name and Address of Beneficial Owner Shares Held  within 60 Days  Number   % Directors and Named Executive Officers            Gregory D. Gorgas(1)  20,446   125,891   146,337   3.5%Connie Matsui(2)  3,778   26,175   29,953  * Steven Kelly(3)  834   5,124   5,958  * Douglas Blayney, M.D.(4)   834   4,900   5,734  * R. Martin Emanuele, Ph.D.(5)  834   4,732   5,566  * Gregory R. Reyes M.D., Ph.D.(6)  -   3,998   3,998  * Tamara A. Favorito(7)  -   1,834   1,834   *                  All Current Directors and Executive Officers as a Group  26,726   172,654   199,380   4.8%                 5% Stockholders                None                

*Less than 1%(1)Consists of 18,046 shares held directly by Gregory D. Gorgas and 2,400 shares held indirectly by Gorgas Family Trust, (ii) 125,891 shares of common stock issuable pursuant to options held directly by Gregory D. Gorgas exercisable within 60 days of February 27, 2025.(2)Consists of 3,778 shares held directly by Connie Matsui (ii) 26,175 shares of common stock issuable pursuant to options held directly by Connie Matsui exercisable within 60 days of February 27, 2025.(3)Consists of 834 shares held by Steven Kelly, (ii) 5,124 shares of common stock issuable pursuant to options held directly by Steven Kelly exercisable within 60 days of February 27, 2025.(4)Consists of 834 shares held by Douglas Blayney, M.D., (ii) 4,900 shares of common stock issuable pursuant to options held directly